Jade Biosciences's total assets for Q4 2024 were $80.33M, a decrease of -10.09% from the previous quarter. JBIO total liabilities were $3.90M for the fiscal quarter, a -96.33% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.